124 related articles for article (PubMed ID: 4043531)
1. A rabies vaccine produced in a non-tumorigenic rabbit cell line.
Sureau P; Perrin P; Horaud F
Dev Biol Stand; 1985; 60():133-9. PubMed ID: 4043531
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and comparative studies of inactivated rabies vaccines obtained in the heterologous diploid and polyploid cells (HAK, BHK and VERO).
Atanasiu P; Perrin P; Segre L; Manganas O
Dev Biol Stand; 1981; 50():173-82. PubMed ID: 7341292
[TBL] [Abstract][Full Text] [Related]
3. Systematically experimental investigation on carcinogenesis or tumorigenicity of VERO cell lines of different karyotypes in nude mice in vivo used for viral vaccine manufacture.
Zhang DL; Ji L; Li LJ; Huang GS
Yi Chuan Xue Bao; 2004 Jul; 31(7):647-60. PubMed ID: 15473315
[TBL] [Abstract][Full Text] [Related]
4. The present status of rabies vaccine development and clinical experience with rabies vaccine.
Roumiantzeff M
Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767
[TBL] [Abstract][Full Text] [Related]
5. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
Rourou S; van der Ark A; van der Velden T; Kallel H
Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
[TBL] [Abstract][Full Text] [Related]
6. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use.
el-Karamany RM
Acta Virol; 1987 Aug; 31(4):321-8. PubMed ID: 2892381
[TBL] [Abstract][Full Text] [Related]
7. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.
Pay TW; Boge A; Menard FJ; Radlett PJ
Dev Biol Stand; 1985; 60():171-4. PubMed ID: 3899780
[TBL] [Abstract][Full Text] [Related]
8. The use of various immunochemical, biochemical and biological methods for the analysis of rabies virus production in tissue cultures.
Adamovicz P; Aguilon F; David A; Le Fur R; Mazert MC; Perrin P; Reculard P; Sureau P
Dev Biol Stand; 1983; 55():191-7. PubMed ID: 6677532
[TBL] [Abstract][Full Text] [Related]
9. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
[TBL] [Abstract][Full Text] [Related]
10. [Economical production of rabies vaccine on cell cultures].
Lalosević D; Lazarević-Ivanc L; Stankov S
Med Pregl; 1997; 50(11-12):565-8. PubMed ID: 9471524
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
[TBL] [Abstract][Full Text] [Related]
12. [Biological characteristics of the adapted rabies virus 3aG-V in Vero cell].
Shi XS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):348-50. PubMed ID: 15650786
[TBL] [Abstract][Full Text] [Related]
13. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
Kallel H; Rourou S; Majoul S; Loukil H
Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of inactivated rabies vaccines obtained from diploid and polyploid heterologous cells (Hak, BHK, and Vero)].
Atanasiu P; Perrin P; Segre L; Manganas O
Arch Inst Pasteur Tunis; 1981; 58(3):401-21. PubMed ID: 7316614
[TBL] [Abstract][Full Text] [Related]
15. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
[TBL] [Abstract][Full Text] [Related]
16. Purified chick embryo cell (PCEC) rabies vaccine for human use. Laboratory data.
Barth R; Gruschkau H; Jaeger O; Milcke L; Weinmann E
Behring Inst Mitt; 1984 Nov; (76):142-54. PubMed ID: 6525146
[TBL] [Abstract][Full Text] [Related]
17. Vero-cell rabies vaccine produced using serum-free medium.
Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
[TBL] [Abstract][Full Text] [Related]
18. Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line.
Montagnon BJ
Dev Biol Stand; 1989; 70():27-47. PubMed ID: 2759353
[TBL] [Abstract][Full Text] [Related]
19. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
[TBL] [Abstract][Full Text] [Related]
20. A new Vero cell rabies vaccine: results of a comparative trial with human diploid cell rabies vaccine in children.
Sabchareon A; Lang J; Attanath P; Sirivichayakul C; Pengsaa K; Le Mener V; Chantavanich P; Prarinyanuphab V; Pojjaroen-Anant C; Nimnual S; Wood SC; Riffard P
Clin Infect Dis; 1999 Jul; 29(1):141-9. PubMed ID: 10433577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
